Medtronic
MDT
2,319 hedge funds and large institutions have $105B invested in Medtronic in 2025 Q4 according to their latest regulatory filings, with 297 funds opening new positions, 884 increasing their positions, 878 reducing their positions, and 107 closing their positions.
178% more first-time investments, than exits
New positions opened: 297 | Existing positions closed: 107
52% more call options, than puts
Call options by funds: $951M | Put options by funds: $627M
7% more funds holding
Funds holding: 2,177 → 2,319 (+142)
5% more funds holding in top 10
Funds holding in top 10: 39 → 41 (+2)
1.63% more ownership
Funds ownership: 83.88% → 85.5% (+1.6%)
3% more capital invested
Capital invested by funds: $102B → $105B (+$2.86B)
1% more repeat investments, than reductions
Existing positions increased: 884 | Existing positions reduced: 878
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Capital Research Global Investors
Los Angeles,
California
|
+$377M |
| 2 |
Wellington Management Group
Boston,
Massachusetts
|
+$308M |
| 3 |
SG Americas Securities
New York
|
+$233M |
| 4 |
Bank of Montreal
Toronto,
Ontario, Canada
|
+$198M |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$183M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
UBS Group
Zurich,
Switzerland
|
-$683M |
| 2 |
Barclays
London,
United Kingdom
|
-$446M |
| 3 |
Pzena Investment Management
New York
|
-$263M |
| 4 |
Lazard Asset Management
New York
|
-$252M |
| 5 |
Bank of New York Mellon
New York
|
-$229M |
MDT Hedge Fund Activity: Q4 2025 in Review
2,319 of the 8,284 institutional investors tracked by Wall St. Rank reported a position in Medtronic (MDT) for Q4 2025, worth a combined $105B — up 2.8% from $102B a quarter earlier.
Buyers outnumbered sellers: 297 funds opened new MDT positions and 107 closed out — a net gain of 190 holders — while 884 added to existing stakes and 878 trimmed.
The largest buyer was Capital Research Global Investors, adding an estimated $377M. The largest seller was UBS Group, cutting an estimated $683M.
- 2,319 institutional investors held Medtronic (MDT) as of Q4 2025, up from 2,177 in Q3 2025.
- Funds reported $105B of Medtronic stock for Q4 2025, up 2.8% quarter-over-quarter.
- 297 funds opened new Medtronic positions in Q4 2025 and 107 closed out, a net change of +190 holders.
- The largest Medtronic buyer in Q4 2025 was Capital Research Global Investors, an estimated $377M added.
- The largest Medtronic seller in Q4 2025 was UBS Group, an estimated $683M sold.
Based on aggregated 13F filings for Q4 2025.